Publication | Open Access
<scp>TDO2</scp> overexpression correlates with poor prognosis, cancer stemness, and resistance to cetuximab in bladder cancer
14
Citations
34
References
2021
Year
Our results indicate that TDO2 might take an essential part in BC progression and could be a potential marker for targeted therapy in BC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1